MedTrace Logo

Enhanced Assisted Reproductive Technology Pregnancy Rate by Prostacyclin Analog (Iloprost)

NCT01549171 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-03-09

No results posted yet for this study

Summary

Human fallopian tube secretes high concentration of prostacyclin. Fallopian tube is the site for early embryo development. The effect of prostacyclin on human early embryo development is waiting to be clarified. The study hypothesis is prostacyclin can enhance early embryo development.

Conditions

  • Pregnancy

Interventions

DRUG

Iloprost

supplement in culture medium during culture in the lab. The concentration is 1 uM.

OTHER

normal saline

Supplement with vehicle only no Iloprost.

Sponsors & Collaborators

  • Origio A/S

    collaborator INDUSTRY

  • Fertility Specialists of Houston

    lead OTHER

Principal Investigators

  • George M Grunert, M.D. · Obstetrical & Gynecological Associates

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-11-30
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01549171 on ClinicalTrials.gov